Effect of Reiki Applied After Coronary Angiography on Pain and Comfort Level

NCT ID: NCT07193784

Last Updated: 2025-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-25

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Coronary angiography is an invasive imaging technique that directly visualizes the anatomical structure of the coronary arteries and is considered the gold standard for diagnosing significant coronary artery disease. In the post-coronary angiography period, alleviating pain and enhancing patient comfort are important goals of clinical care. Reiki is an energy-based complementary therapy aimed at supporting the body's natural healing processes and promoting relaxation. Among non-pharmacological interventions, Reiki-a practice rooted in Traditional Chinese Medicine and meaning universal life energy-is a safe, cost-effective, and easily applicable method. Studies have shown that Reiki is effective in reducing pain, anxiety, fear, and stress, as well as in improving comfort and holistic well-being. This study was designed to examine the effects of Reiki therapy administered after coronary angiography on patients' levels of pain and comfort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Angiography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, single-blind, placebo-controlled, parallel-group trial with three arms (Reiki, sham Reiki, and control). Participants are allocated in a 1:1:1 ratio and receive only the intervention assigned to their group. No crossover between arms is planned.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participants are blinded to their group allocation. Reiki and sham Reiki sessions are delivered in identical settings (duration, environment, body position, and practitioner interaction) to maintain blinding. Practitioners, who also serve as data collectors, are aware of the intervention type due to the nature of the technique. Statistical analysis will be performed by an independent researcher blinded to group allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Reiki

Participants receive a 30-minute Reiki session by a trained practitioner after coronary angiography. Pain and comfort are assessed at four time points.

Group Type EXPERIMENTAL

Reiki

Intervention Type BEHAVIORAL

Reiki therapy applied by trained practitioner for 30 minutes.

Sham reiki

Participants receive a 30-minute sham Reiki session mimicking Reiki hand positions without actual energy intervention. Pain and comfort are assessed at the same time points.

Group Type PLACEBO_COMPARATOR

Sham reiki

Intervention Type BEHAVIORAL

Sham Reiki applied by same practitioner, mimicking Reiki without actual energy technique.

Control

Participants receive standard post-angiography care without any Reiki or sham intervention. Pain and comfort are assessed at the same time points.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reiki

Reiki therapy applied by trained practitioner for 30 minutes.

Intervention Type BEHAVIORAL

Sham reiki

Sham Reiki applied by same practitioner, mimicking Reiki without actual energy technique.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18-80 years.
* Undergoing coronary angiography for the first time.
* No additional interventions (e.g., stent placement) performed during angiography.
* Coronary angiography performed via femoral artery.
* Elective (non-emergency) coronary angiography.
* No prior experience with Reiki, Therapeutic Touch, or other energy therapies.
* Able to understand and speak Turkish.
* Open to communication and able to participate in face-to-face interviews.

Exclusion Criteria

* Development of acute complications during or after coronary angiography (e.g., myocardial infarction, severe arrhythmia, embolism, bleeding at the intervention site, hematoma).
* Any diagnosed psychiatric disorder.
* History of chronic pain or regular use of analgesics.
* Previous experience with Reiki or similar complementary therapies.
* Requirement for sedative or opioid analgesic use during the study period.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mersin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abdullah Avcı

Abdullah Avcı, PhD, Principal Investigator, Nursing Services Coordinator, Mersin University Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mersin University Hospital

Mersin, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Abdullah Avcı, PhD

Role: CONTACT

+903242410000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Abdullah Avcı, PhD

Role: primary

+903242410000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AVCI-MERSİN-2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.